Koopmann Matthias, Hong KyungPyo, Kholmovski Eugene G, Huang Eric C, Hu Nan, Ying Jian, Levenson Richard, Vijayakumar Sathya, Dosdall Derek J, Ranjan Ravi, Kim Daniel
Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital of Münster, Münster, Germany.
NMR Biomed. 2014 Aug;27(8):988-95. doi: 10.1002/nbm.3135. Epub 2014 May 28.
Both post-contrast myocardial T1 and extracellular volume (ECV) measurements have been associated with diffuse interstitial fibrosis. The cardiovascular magnetic resonance (CMR) field is migrating towards ECV, because it is largely insensitive to confounders that affect post-contrast myocardial T1 . Despite the theoretical advantages of myocardial ECV over post-contrast myocardial T1 , systematic experimental studies comparing the two measurements are largely lacking. We sought to measure the temporal changes in post-contrast myocardial T1 and ECV in an established canine model with chronic atrial fibrillation. Seventeen mongrel dogs, implanted with a pacemaker to induce chronic atrial fibrillation via rapid atrial pacing, were scanned multiple times for a total of 46 CMR scans at 3T. These dogs with different disease durations (0-22 months) were part of a separate longitudinal study aimed at studying the relationship between AF and pathophysiology. In each animal, we measured native and post-contrast T1 values and hematocrit. Temporal changes in post-contrast myocardial T1 and ECV, as well as other CMR parameters, were modeled with linear mixed effect models to account for repeated measurements over disease duration. In 17 animals, post-contrast myocardial T1 decreased significantly from 872 to 698 ms (p < 0.001), which corresponds to a 24.9% relative reduction. In contrast, ECV increased from 21.0 to 22.0% (p = 0.38), which corresponds to only a 4.5% relative increase. To partially investigate this discrepancy, we quantified collagen volume fraction (CVF) in post-mortem heart tissues of six canines sacrificed at different disease durations (0-22 months). CVF quantified by histology increased from 0.9 to 1.9% (p = 0.56), which agrees better with ECV than with post-contrast myocardial T1 . This study shows that post-contrast myocardial T1 and ECV may disagree in a longitudinal canine study. A more comprehensive study, including histologic, cardiac, and renal functional analyses, is warranted to test rigorously which CMR parameter (ECV or post-contrast myocardial T1 ) agrees better with CVF.
对比剂增强后心肌T1值和细胞外容积(ECV)测量均与弥漫性间质纤维化相关。心血管磁共振(CMR)领域正在向ECV转变,因为它在很大程度上不受影响对比剂增强后心肌T1值的混杂因素的影响。尽管心肌ECV相对于对比剂增强后心肌T1值具有理论优势,但比较这两种测量方法的系统性实验研究在很大程度上仍然缺乏。我们试图在一个已建立的慢性心房颤动犬模型中测量对比剂增强后心肌T1值和ECV的时间变化。17只杂种犬通过快速心房起搏植入起搏器以诱导慢性心房颤动,在3T下进行多次扫描,共进行46次CMR扫描。这些患有不同疾病持续时间(0 - 22个月)的犬是一项旨在研究心房颤动与病理生理学之间关系的单独纵向研究的一部分。在每只动物中,我们测量了对比剂增强前和增强后的T1值以及血细胞比容。使用线性混合效应模型对对比剂增强后心肌T1值和ECV以及其他CMR参数的时间变化进行建模,以考虑疾病持续时间内的重复测量。在17只动物中,对比剂增强后心肌T1值从872毫秒显著降至698毫秒(p < 0.001),相对降低了24.9%。相比之下,ECV从21.0%增加到22.0%(p = 0.38),相对仅增加了4.5%。为了部分探究这种差异,我们对在不同疾病持续时间(0 - 22个月)处死的6只犬的死后心脏组织中的胶原容积分数(CVF)进行了定量分析。通过组织学定量的CVF从0.9%增加到1.9%(p = 0.56),与ECV的一致性比与对比剂增强后心肌T1值更好。这项研究表明,在纵向犬类研究中,对比剂增强后心肌T1值和ECV可能不一致。需要进行更全面的研究,包括组织学、心脏和肾功能分析,以严格测试哪个CMR参数(ECV或对比剂增强后心肌T